Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

Comprehensive Computed Tomography Radiomics Analysis of Lung Adenocarcinoma for Prognostication.

Lee G, Park H, Sohn I, Lee SH, Song SH, Kim H, Lee KS, Shim YM, Lee HY.

Oncologist. 2018 Apr 5. pii: theoncologist.2017-0538. doi: 10.1634/theoncologist.2017-0538. [Epub ahead of print]

PMID:
29622699
2.

Long-term survival in locally advanced non-small cell lung cancer invading the great vessels and heart.

Park B, Cho JH, Kim HK, Choi YS, Zo JI, Shim YM, Kim J.

Thorac Cancer. 2018 Mar 30. doi: 10.1111/1759-7714.12625. [Epub ahead of print]

PMID:
29602232
3.

Prognostic significance of histologic classification and tumor disappearance rate by computed tomography in lung cancer.

Kim D, Kim HK, Kim SH, Lee HY, Cho JH, Choi YS, Kim K, Kim J, Zo JI, Shim YM.

J Thorac Dis. 2018 Jan;10(1):388-397. doi: 10.21037/jtd.2017.12.38.

4.

Temporal and regional distribution of initial recurrence site in completely resected N1-stage II lung adenocarcinoma: The effect of postoperative adjuvant chemotherapy.

Park BJ, Cho JH, Lee JH, Shin S, Kim HK, Choi YS, Zo JI, Shim YM, Sun JM, Lee SH, Ahn JS, Ahn MJ, Park K, Kim J.

Lung Cancer. 2018 Mar;117:7-13. doi: 10.1016/j.lungcan.2018.01.004. Epub 2018 Jan 6.

PMID:
29496256
5.

Validation of claims-based algorithms for pulmonary arterial hypertension.

Papani R, Sharma G, Agarwal A, Callahan SJ, Chan WJ, Kuo YF, Shim YM, Mihalek AD, Duarte AG.

Pulm Circ. 2018 Apr-Jun;8(2):2045894018759246. doi: 10.1177/2045894018759246.

6.

Extended sleeve lobectomy for centrally located non-small-cell lung cancer: a 20-year single-centre experience.

Hong TH, Cho JH, Shin S, Kim HK, Choi YS, Zo JI, Shim YM, Kim J.

Eur J Cardiothorac Surg. 2018 Feb 2. doi: 10.1093/ejcts/ezy011. [Epub ahead of print]

PMID:
29408983
7.

Recurrence dynamics after trimodality therapy (Neoadjuvant concurrent chemoradiotherapy and surgery) in patients with stage IIIA (N2) lung cancer.

Lee J, Kim HK, Park BJ, Cho JH, Choi YS, Zo JI, Shim YM, Pyo H, Ahn YC, Ahn JS, Ahn MJ, Park K, Kim J.

Lung Cancer. 2018 Jan;115:89-96. doi: 10.1016/j.lungcan.2017.11.020. Epub 2017 Nov 22.

PMID:
29290268
8.

Bronchial biopsy specimen as a surrogate for DNA methylation analysis in inoperable lung cancer.

Um SW, Kim HK, Kim Y, Lee BB, Kim D, Han J, Kim H, Shim YM, Kim DH.

Clin Epigenetics. 2017 Dec 20;9:131. doi: 10.1186/s13148-017-0432-5. eCollection 2017.

9.

Metformin induces cell cycle arrest at the G1 phase through E2F8 suppression in lung cancer cells.

Jin DH, Kim Y, Lee BB, Han J, Kim HK, Shim YM, Kim DH.

Oncotarget. 2017 Oct 6;8(60):101509-101519. doi: 10.18632/oncotarget.21552. eCollection 2017 Nov 24.

10.

Development and validation of the smart management strategy for health assessment tool-short form (SAT-SF) in cancer survivors.

Yun YH, Jung JY, Sim JA, Lee J, Noh DY, Han W, Park KJ, Jeong SY, Park JW, Wu HG, Chie EK, Kim HJ, Jung KH, Zo JI, Kim S, Lee JE, Nam SJ, Lee ES, Oh JH, Kim YW, Kim YT, Shim YM.

Qual Life Res. 2018 Feb;27(2):347-354. doi: 10.1007/s11136-017-1723-1. Epub 2017 Oct 30.

PMID:
29086167
11.

Lung Cancer Risk and Residential Exposure to Air Pollution: A Korean Population-Based Case-Control Study.

Lamichhane DK, Kim HC, Choi CM, Shin MH, Shim YM, Leem JH, Ryu JS, Nam HS, Park SM.

Yonsei Med J. 2017 Nov;58(6):1111-1118. doi: 10.3349/ymj.2017.58.6.1111.

12.

Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer.

Sun JM, Noh JM, Oh D, Kim HK, Lee SH, Choi YS, Pyo H, Ahn JS, Jung SH, Ahn YC, Kim J, Ahn MJ, Zo JI, Shim YM, Park K.

J Thorac Oncol. 2017 Dec;12(12):1806-1813. doi: 10.1016/j.jtho.2017.09.1954. Epub 2017 Sep 28.

PMID:
28962948
13.

Factors related with colorectal and stomach cancer screening practice among disease-free lung cancer survivors in Korea.

Park SM, Lee J, Kim YA, Chang YJ, Kim MS, Shim YM, Zo JI, Yun YH.

BMC Cancer. 2017 Aug 30;17(1):600. doi: 10.1186/s12885-017-3583-z.

14.

Ipsilateral pleural recurrence after diagnostic transthoracic needle biopsy in pathological stage I lung cancer patients who underwent curative resection.

Moon SM, Lee DG, Hwang NY, Ahn S, Lee H, Jeong BH, Choi YS, Shim YM, Kim TJ, Lee KS, Kim H, Kwon OJ, Lee KJ.

Lung Cancer. 2017 Sep;111:69-74. doi: 10.1016/j.lungcan.2017.07.008. Epub 2017 Jul 12.

PMID:
28838402
15.

JOURNAL CLUB: Doubling Time of Thymic Epithelial Tumors Correlates With World Health Organization Histopathologic Classification.

Jeong DY, Lee KS, Chung MJ, Zo JI, Shim YM, Moon JW.

AJR Am J Roentgenol. 2017 Oct;209(4):W202-W210. doi: 10.2214/AJR.17.17836. Epub 2017 Aug 10.

PMID:
28796544
16.

Comparison of fatigue, depression, and anxiety as factors affecting posttreatment health-related quality of life in lung cancer survivors.

Jung JY, Lee JM, Kim MS, Shim YM, Zo JI, Yun YH.

Psychooncology. 2018 Feb;27(2):465-470. doi: 10.1002/pon.4513. Epub 2017 Aug 17.

PMID:
28755492
17.

Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.

Noh KW, Lee MS, Lee SE, Song JY, Shin HT, Kim YJ, Oh DY, Jung K, Sung M, Kim M, An S, Han J, Shim YM, Zo JI, Kim J, Park WY, Lee SH, Choi YL.

J Pathol. 2017 Nov;243(3):307-319. doi: 10.1002/path.4950. Epub 2017 Sep 28.

PMID:
28741662
18.

Programmed Death Ligand 1 Expression in Paired Non-Small Cell Lung Cancer Tumor Samples.

Cho JH, Sorensen SF, Choi YL, Feng Y, Kim TE, Choi H, Georgsen JB, Dolled-Filhart M, Emancipator K, Meldgaard P, Sun JM, Kim HK, Choi YS, Shim YM, Zhou W, Hager H, Kim J.

Clin Lung Cancer. 2017 Nov;18(6):e473-e479. doi: 10.1016/j.cllc.2017.04.008. Epub 2017 Apr 24.

PMID:
28669849
19.

Gastrointestinal stromal tumours of the oesophagus: a clinicopathological and molecular analysis of 27 cases.

Kang G, Kang Y, Kim KH, Ha SY, Kim JY, Shim YM, Heinrich MC, Kim KM, Corless CL.

Histopathology. 2017 Nov;71(5):805-812. doi: 10.1111/his.13292. Epub 2017 Sep 6.

PMID:
28644569
20.

Treatment outcomes in patients with extranodal marginal zone B-cell lymphoma of the lung.

Lee H, Yang B, Nam B, Jeong BH, Shin S, Zo JI, Shim YM, Kwon OJ, Lee KS, Kim H.

J Thorac Cardiovasc Surg. 2017 Jul;154(1):342-349. doi: 10.1016/j.jtcvs.2017.03.043. Epub 2017 Mar 21.

PMID:
28457544
21.

Squamous Cell Carcinoma Arising from the Pleural Cavity After Pneumonectomy for Chronic Empyema.

Jeon YJ, Shin S, Shim YM.

Korean J Thorac Cardiovasc Surg. 2017 Apr;50(2):123-125. doi: 10.5090/kjtcs.2017.50.2.123. Epub 2017 Apr 5.

22.

Outcomes of Curative-Intent Surgery and Adjuvant Treatment for Pulmonary Large Cell Neuroendocrine Carcinoma.

Kim KW, Kim HK, Kim J, Shim YM, Ahn MJ, Choi YL.

World J Surg. 2017 Jul;41(7):1820-1827. doi: 10.1007/s00268-017-3908-8.

PMID:
28204910
23.

Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience.

Park H, Oh D, Ahn YC, Pyo H, Noh JM, Sun JM, Ahn JS, Ahn MJ, Park K, Kim HK, Choi YS, Kim J, Zo JI, Shim YM.

Cancer Res Treat. 2017 Oct;49(4):880-889. doi: 10.4143/crt.2016.442. Epub 2016 Dec 12.

24.

Intensive care unit (ICU) readmission after major lung resection: Prevalence, patterns, and mortality.

Jung JJ, Cho JH, Hong TH, Kim HK, Choi YS, Kim J, Shim YM, Zo JI.

Thorac Cancer. 2017 Jan;8(1):33-39. doi: 10.1111/1759-7714.12406. Epub 2016 Dec 7.

25.

Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma.

Song SH, Park H, Lee G, Lee HY, Sohn I, Kim HS, Lee SH, Jeong JY, Kim J, Lee KS, Shim YM.

J Thorac Oncol. 2017 Apr;12(4):624-632. doi: 10.1016/j.jtho.2016.11.2230. Epub 2016 Dec 5.

26.

Pathologic stratification of operable lung adenocarcinoma using radiomics features extracted from dual energy CT images.

Bae JM, Jeong JY, Lee HY, Sohn I, Kim HS, Son JY, Kwon OJ, Choi JY, Lee KS, Shim YM.

Oncotarget. 2017 Jan 3;8(1):523-535. doi: 10.18632/oncotarget.13476.

27.

A Randomized Phase II Study of Leucovorin/5-Fluorouracil with or without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-Resected, Node-Positive Esophageal Squamous Cell Carcinoma.

Lim SH, Shim YM, Park SH, Kim HK, Choi YS, Ahn MJ, Park K, Zo JI, Sun JM.

Cancer Res Treat. 2017 Jul;49(3):816-823. doi: 10.4143/crt.2016.417. Epub 2016 Nov 9.

28.

Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation.

Han CZ, Juncadella IJ, Kinchen JM, Buckley MW, Klibanov AL, Dryden K, Onengut-Gumuscu S, Erdbr├╝gger U, Turner SD, Shim YM, Tung KS, Ravichandran KS.

Nature. 2016 Nov 24;539(7630):570-574. doi: 10.1038/nature20141. Epub 2016 Nov 7.

29.

Joint effect of airflow limitation and emphysema on postoperative outcomes in early-stage nonsmall cell lung cancer.

Shin S, Park HY, Kim H, Kim HK, Choi YS, Kim J, Um SW, Chung MJ, Kim H, Kwon OJ, Zo JI, Guallar E, Cho J, Shim YM.

Eur Respir J. 2016 Dec;48(6):1743-1750. doi: 10.1183/13993003.01148-2016. Epub 2016 Nov 3.

PMID:
27811074
30.

Limited thymectomy as a potential alternative treatment option for early-stage thymoma: A multi-institutional propensity-matched study.

Narm KS, Lee CY, Do YW, Jung HS, Byun GE, Lee JG, Kim DJ, Hwang Y, Park IK, Kang CH, Kim YT, Cho JH, Choi YS, Kim J, Shim YM, Hwang SK, Kim YH, Kim DK, Park SI, Chung KY; Korea Association for Research on the Thymus.

Lung Cancer. 2016 Nov;101:22-27. doi: 10.1016/j.lungcan.2016.06.021. Epub 2016 Sep 7.

PMID:
27794404
31.

Dynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinoma.

Kim W, Lee HY, Jung SH, Woo MA, Kim HK, Choi YS, Kim J, Zo JI, Shim YM, Han J, Jeong JY, Choi JY, Lee KS.

Oncotarget. 2017 May 9;8(19):32201-32211. doi: 10.18632/oncotarget.12920.

32.

Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery.

Cho WK, Oh D, Ahn YC, Shim YM, Zo JI, Sun JM, Ahn MJ, Park K.

Oncotarget. 2017 Jan 10;8(2):3542-3552. doi: 10.18632/oncotarget.12200.

33.

Pathologic heterogeneity of lung adenocarcinomas: A novel pathologic index predicts survival.

Lee G, Choi ER, Lee HY, Jeong JY, Ahn JH, Kim S, Bae J, Kim HK, Choi YS, Kim J, Zo J, Lee KS, Shim YM.

Oncotarget. 2016 Oct 25;7(43):70353-70363. doi: 10.18632/oncotarget.11857.

34.

Quantitative image variables reflect the intratumoral pathologic heterogeneity of lung adenocarcinoma.

Choi ER, Lee HY, Jeong JY, Choi YL, Kim J, Bae J, Lee KS, Shim YM.

Oncotarget. 2016 Oct 11;7(41):67302-67313. doi: 10.18632/oncotarget.11693.

35.

Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer.

Jang HJ, Lee HS, Burt BM, Lee GK, Yoon KA, Park YY, Sohn BH, Kim SB, Kim MS, Lee JM, Joo J, Kim SC, Yun JS, Na KJ, Choi YL, Park JL, Kim SY, Lee YS, Han L, Liang H, Mak D, Burks JK, Zo JI, Sugarbaker DJ, Shim YM, Lee JS.

Gut. 2017 Feb;66(2):215-225. doi: 10.1136/gutjnl-2015-311238. Epub 2016 Aug 9.

36.

Overexpression of ╬▓-Catenin and Cyclin D1 is Associated with Poor Overall Survival in Patients with Stage IA-IIA Squamous Cell Lung Cancer Irrespective of Adjuvant Chemotherapy.

Kim Y, Jin D, Lee BB, Cho EY, Han J, Shim YM, Kim HK, Kim DH.

J Thorac Oncol. 2016 Dec;11(12):2193-2201. doi: 10.1016/j.jtho.2016.07.021. Epub 2016 Aug 4.

37.

Prognostic factors after pulmonary metastasectomy of colorectal cancers: influence of liver metastasis.

Kim S, Kim HK, Cho JH, Choi YS, Kim K, Kim J, Zo JI, Shim YM, Heo JS, Lee WY, Kim HC.

World J Surg Oncol. 2016 Jul 29;14(1):201. doi: 10.1186/s12957-016-0940-3.

38.

Prognostic value of quality of life score in disease-free survivors of surgically-treated lung cancer.

Yun YH, Kim YA, Sim JA, Shin AS, Chang YJ, Lee J, Kim MS, Shim YM, Zo JL.

BMC Cancer. 2016 Jul 20;16:505. doi: 10.1186/s12885-016-2504-x.

39.

Do New pN Subclassifications Proposed by IASLC's Lung Cancer Staging Project Agree with ypN Categories after Trimodality Therapy for Initial N2 Disease?

Kim H, Ahn YC, Pyo H, Oh D, Noh JM, Sun JM, Ahn JS, Ahn MJ, Park K, Choi YS, Kim J, Zo JI, Shim YM, Lee M, Han J.

J Thorac Oncol. 2016 Dec;11(12):2202-2207. doi: 10.1016/j.jtho.2016.07.005. Epub 2016 Jul 14.

40.

Predictors of survival in patients who underwent video-assisted thoracic surgery talc pleurodesis for malignant pleural effusion.

Yoon DW, Cho JH, Choi YS, Kim J, Kim HK, Zo JI, Shim YM.

Thorac Cancer. 2016 Jul;7(4):393-8. doi: 10.1111/1759-7714.12354. Epub 2016 May 5.

41.

Ultrapressure liquid chromatography-tandem mass spectrometry assay using atmospheric pressure photoionization (UPLC-APPI-MS/MS) for quantification of 4-methoxydiphenylmethane in pharmacokinetic evaluation.

Farhan N, Fitzpatrick S, Shim YM, Paige M, Chow DS.

J Pharm Biomed Anal. 2016 Sep 5;128:46-52. doi: 10.1016/j.jpba.2016.05.014. Epub 2016 May 10.

PMID:
27232150
42.

Simultaneous Resection of Synchronous Esophageal and Gastric Cancers.

Park B, Kim HK, Choi YS, Kim J, Zo JI, Shim YM.

Thorac Cardiovasc Surg. 2016 Oct;64(7):611-618. Epub 2016 May 5.

PMID:
27148930
43.

Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease.

Kim HK, Cho JH, Choi YS, Zo JI, Shim YM, Park K, Ahn MJ, Ahn YC, Kim K, Kim J.

Lung Cancer. 2016 Jun;96:56-62. doi: 10.1016/j.lungcan.2016.03.016. Epub 2016 Mar 29.

PMID:
27133751
44.

Prognostic Significance of PD-L1 in Patients with Non-Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected Cases.

Sun JM, Zhou W, Choi YL, Choi SJ, Kim SE, Wang Z, Dolled-Filhart M, Emancipator K, Wu D, Weiner R, Frisman D, Kim HK, Choi YS, Shim YM, Kim J.

J Thorac Oncol. 2016 Jul;11(7):1003-11. doi: 10.1016/j.jtho.2016.04.007. Epub 2016 Apr 18.

45.

PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.

Kim HS, Lee SE, Bae YS, Kim DJ, Lee CG, Hur J, Chung H, Park JC, Shin SK, Lee SK, Lee YC, Kim HR, Shim YM, Jewell SS, Kim H, Choi YL, Cho BC.

Oncotarget. 2016 May 24;7(21):30691-701. doi: 10.18632/oncotarget.8749.

46.

Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.

Lee HY, Cha MJ, Lee KS, Lee HY, Kwon OJ, Choi JY, Kim HK, Choi YS, Kim J, Shim YM.

J Thorac Oncol. 2016 Jul;11(7):1064-73. doi: 10.1016/j.jtho.2016.03.011. Epub 2016 Mar 22.

47.

Anatomic and Functional Evaluation of Central Lymphatics With Noninvasive Magnetic Resonance Lymphangiography.

Kim EY, Hwang HS, Lee HY, Cho JH, Kim HK, Lee KS, Shim YM, Zo J.

Medicine (Baltimore). 2016 Mar;95(12):e3109. doi: 10.1097/MD.0000000000003109.

48.

Pulmonary Intravascular Lymphomatosis: Clinical, CT, and PET Findings, Correlation of CT and Pathologic Results, and Survival Outcome.

Cha MJ, Lee KS, Hwang HS, Kim TJ, Kim TS, Kim BT, Ko YH, Shim YM.

Radiology. 2016 Aug;280(2):602-10. doi: 10.1148/radiol.2016151706. Epub 2016 Mar 4.

PMID:
26943231
49.

Prognostic significance of volume-based 18F-FDG PET/CT parameter in patients with surgically resected non-small cell lung cancer. Comparison with immunohistochemical biomarkers.

Lee JY, Choi JY, Heo JH, Han J, Jang SJ, Kim K, Kim J, Shim YM, Kim BT.

Nuklearmedizin. 2016;55(1):7-14. doi: 10.3413/Nukmed-0754-15-07. Epub 2015 Nov 17.

PMID:
26875430
50.

Management of post-pneumonectomy syndrome using tissue expanders.

Jung JJ, Cho JH, Kim HK, Choi YS, Kim J, Zo JI, Shim YM.

Thorac Cancer. 2016 Jan;7(1):88-93. doi: 10.1111/1759-7714.12282. Epub 2015 Jun 5.

Supplemental Content

Support Center